Tag Archives: Pediatric

FDA Approves Alkindi Sprinkle (hydrocortisone oral granules) for Pediatric Adrenocortical Insufficiency

FDA Approves Alkindi Sprinkle (hydrocortisone oral granules) for Pediatric Adrenocortical Insufficiency DEER PARK, Ill., Sept. 29, 2020 (GLOBE NEWSWIRE) — Eton Pharmaceuticals, Inc (Nasdaq: ETON), a specialty pharmaceutical company focused on developing and commercializing innovative treatments for rare pediatric diseases, today announced that the U.S. Food and Drug Administration (FDA) has approved Alkindi Sprinkle (hydrocortisone)… Read More »

Pediatric Group Issues Updated ADHD Guidelines

MONDAY, Sept. 30, 2019 — Attention-deficit/hyperactivity disorder (ADHD) is in the news a lot, and now newer research has prompted a leading pediatricians’ group to update its guidelines for diagnosing and treating the disorder for the first time since 2011. Dr. Mark Wolraich, lead author of the guidelines, noted that there weren’t any dramatic differences… Read More »

Quality Improvement Strategies Benefit Care Delivery in Pediatric Headache – Neurology Advisor

Using Pediatric Migraine Disability Assessment (PedMIDAS) and headache action plans (HAPs), key quality measures in the treatment of pediatric headache were improved and provided measurable cost savings, according to a study published in Neurology: Clinical Practice. In 2014, the American Academy of Neurology identified 10 areas of underperformance in the prevention and treatment of headache,… Read More »

Sprycel (dasatinib) Tablets Now Approved in Combination with Chemotherapy in Certain Pediatric Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Print this page PRINCETON, N.J.–(BUSINESS WIRE)–Bristol-Myers Squibb Company (NYSE:BMY) today announced the U.S. Food and Drug Administration (FDA) has expanded the indication for Sprycel ® (dasatinib) tablets to include the treatment of pediatric patients one year of age and older with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL) in combination with chemotherapy.1 Sprycel… Read More »